Sanofi-Aventis

Registered Principal Details

Business Or Interest:
Pharmaceutical Manufacturing

Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.

CEO Name:
Anne Whitaker
Vice President

Contact
JD
Joseph Devaney
55 Corporate Drive, Mail Stop 5A-500A P.O. Box 5925
Bridgewater, NJ 08807
(908) 981-4988
(908) 203-7307
joseph.devaney@sanofi.com
http://www.sanofi.us

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Russell Sobotta Exclusive Duties N/A Authorized On 12/21/2012 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 292
Assembly Bill 292
Relating to: therapeutic alternate drug selections in nursing homes, performance of patient services by a pharmacist, and the practice of pharmacy.

Bill Text and History

Other
Notification Date
1/22/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 392
Assembly Bill 392
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)

Bill Text and History

For
Notification Date
2/6/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 502
Assembly Bill 502
Relating to: the use of an epinephrine auto-injector on school premises or at a school-sponsored activity.

Bill Text and History

Other
Notification Date
1/22/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 251
Senate Bill 251
Relating to: therapeutic alternate drug selections in nursing homes, performance of patient services by a pharmacist, and the practice of pharmacy.

Bill Text and History

2013 Wisconsin Act 294

Other
Notification Date
1/22/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 375
Senate Bill 375
Relating to: the use of an epinephrine auto-injector on school premises or at a school-sponsored activity.

Bill Text and History

2013 Wisconsin Act 239

Other
Notification Date
1/22/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Budget Bill Subjects

Health Services: Medical Assistance and Related Programs -- Administration
Biennial budget bill treatment of matter relating to
Health Services: Medical Assistance and Related Programs -- Administration

Notification Date
6/22/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Pharmaceuticals/Biotechnology research and development
Development, drafting or introduction of a proposal relating to
Pharmaceuticals/Biotechnology research and development

Action Intended To Affect
Both Legislative matter and rule

Notification Date
6/22/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Research and development tax credits
Development, drafting or introduction of a proposal relating to
Research and development tax credits

Action Intended To Affect
Both Legislative matter and rule

Notification Date
6/22/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
Total Lobbying Expenditures 2013
January - June
$19,183.43
2013
July - December
$24,026.08
2014
January - June
$21,865.74
2014
July - December
$0.00
Total $65,075.24
Total Hours Communicating 2013
January - June
17.00
2013
July - December
20.00
2014
January - June
35.00
2014
July - December
0.00
Total 72.00
Total Hours Other 2013
January - June
11.50
2013
July - December
11.50
2014
January - June
20.00
2014
July - December
0.00
Total 43.00

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: the use of an epinephrine auto-injector on school premises or at a school-sponsored activity.
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
25%
2014
January - June
5%
2014
July - December
Total 10%
Relating to: the use of an epinephrine auto-injector on school premises or at a school-sponsored activity.
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
25%
2014
January - June
5%
2014
July - December
Total 10%
Relating to: therapeutic alternate drug selections in nursing homes, performance of patient services by a pharmacist, and the practice of pharmacy.
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
2014
January - June
10%
2014
July - December
Total 5%
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
2014
January - June
10%
2014
July - December
Total 5%
Relating to: therapeutic alternate drug selections in nursing homes, performance of patient services by a pharmacist, and the practice of pharmacy.
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
2014
January - June
15%
2014
July - December
Total 7%

Budget Bill Subjects

2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
20%
2013
July - December
2014
January - June
30%
2014
July - December
Total 20%

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
10%
2013
July - December
2014
January - June
2014
July - December
Total 2%
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
10%
2013
July - December
2014
January - June
5%
2014
July - December
Total 5%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
30%
2013
July - December
50%
2014
January - June
10%
2014
July - December
Total 26%

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
30%
2013
July - December
2014
January - June
10%
2014
July - December
Total 12%

Filed Statements of Lobbying Activity and Expenditures